Clarivate Launches DRG Fusion – New Life Science Analytics Product Powered by Real-World Data Investing.com

The new modular analytics solution enables commercial teams to optimize strategies and improve patient outcomes

LONDON, January 14, 2025 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of DRG Fusion, an innovative platform to support commercial analytics in the life sciences. Powered by integrated real-world data and built by clinical and data science experts, Fusion provides biopharma and medtech organizations with the tools to understand and act across diverse disease and competitive landscapes” by eliminating the complexity of managing raw data.

Biopharma and medtech organizations face increasing challenges in extracting insights from fragmented data sources while adapting to competitive pressures and changing market demands. Fusion solves these problems by delivering market data and analytics from integrated medical and pharmaceutical claims and other real-world data sources, empowering life science organizations to create a healthier future. Its user-tested workflows and ongoing data refreshes empower teams to quickly identify gaps in product positioning and uncover opportunities to improve patient acquisition and retention.

Fusion addresses the critical needs of biopharmacology and medical commercial, sales, and marketing teams by offering modular data analytics products aligned with functional team needs. Pre-built modules provide users with configurable dashboards to support patient journey analysis, commercial targeting, market access optimization and patient segmentation.

Abeezer TapiaSenior Vice President and General Manager, Real World Data, Life Sciences & Healthcare, Clarivate said: “Fusion is built to leverage real-world data in specific ways to help our customers maximize product value. Its four product workflows meet specific goals” whether it’s sizing and segmenting target patient populations, identifying and mitigating leak points during patient journey, deploying sales teams based on precise commercial targeting, or designing value messaging and outreach programs to optimize access with data mastered at the drug and device level, Fusion provides targeted market insights critical to decision-making about biopharmaceutics and medicine.”

Henry LevyPresident, Life Sciences & Healthcare, Clarivate, added: “Fusion demonstrates the robustness of life science data from Clarivate and its broad commercial applications. Its scalable data architecture has been carefully designed to rapidly deliver disease insights to patients and subpopulations. We are committed to investing in innovative technologies that empower our customers to address the most pressing challenges in healthcare , which will launch at Fusion in 2025, we remain focused on delivering customer-centric solutions that deliver significant value and impact for our customers.”

Fusion streamlines the data management and querying process for life science organizations by simplifying complex data analysis with out-of-the-box, informative visuals and tables that accelerate commercial decisions.

To learn more about how this modular analytics platform can help organizations optimize their product launch and growth strategies while improving patient outcomes, visit here.

About Clarivate real-world data

Clarivate offers a unique blend of products and expert consulting to support every stage of your Real World Data (RWD) journey. Our platform seamlessly integrates medical and pharmaceutical claims, SDoH, mortality and registry data to deliver valuable insights across the development lifecycle. With group-specific data tailored to your needs, we provide precise answers to key business questions. Our modular analytics platform, designed by scientists, epidemiologists and former clinicians, provides actionable insights to improve your commercial strategy. We also offer expert support in data configuration, advanced ML models, and integration of disparate datasets to ensure you have the tools and expertise to succeed. Offerings include Clarivate Real-World Data Nucleus, Clarivate Real-World Data Fusion Platform, Clarivate Consulting and insight into real-world data and the Clarivate franchise of real-world rare disease data.

About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights and analytics, workflow solutions, and professional services in academia and government, intellectual property, and life sciences and healthcare. For more information, visit www.Clarivate.com.

Media contact:
Catherine DanielDirector, External communicationsLife Sciences and Healthcare
newsroom@Clarivate.com